All Journals
All Articles
|
Search
Log In
About
About the Journal
Aims and Scope
Editorial Policies
Editorial Board
Early‑Career Editorial Board
News
Journal History
Partners
Advertise
Contact Us
Publish with us
For Authors
Author Instructions
Article Processing Charges
Editorial Process
Manuscript Templates
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Articles
All Articles
Editor’s Choice
Articles with Video Abstracts
Video Abstract Guidelines
Special Topics
All Special Topics
Ongoing Special Topics
Completed Special Topics
Special Topic Ebooks
Special Topic Guidelines
Volumes
Features
Webinars
Interviews
+ Subscribe
Submit
Articles
Special Topics
Volumes
Webinars
Videos
Menu
Please enter the verification code in the image
Please enter the verification code in the image
Articles
Special Topics
Volumes
Webinars
Interviews
Home
Volumes
Volume
Targeting MYC-driven lymphoma: lessons learned and future directions
Cancer stem cells in drug resistance: an introduction to the e-book covering the special issue on the “Cancer Stem Cells and Drug Resistance”
How acute myeloid leukemia (AML) escapes from FMS-related tyrosine kinase 3 (FLT3) inhibitors? Still an overrated complication?
miR-16-5p enhances sensitivity to RG7388 through targeting <i>PPM1D</i> expression (WIP1) in Childhood Acute Lymphoblastic Leukemia
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
Mitochondria in colorectal cancer stem cells - a target in drug resistance
Fungal mycobiome-mediated immune response: a non-negligible promoter in pancreatic oncogenesis and chemoresistance
Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma
Importance of <i>ROS1</i> gene fusions in non-small cell lung cancer
The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer
Immune checkpoint inhibitors in ovarian cancer: where do we go from here?
Interaction of pregnane X receptor with hypoxia-inducible factor-1 regulates chemoresistance of prostate cancer cells
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors
Actions for 0 selected articles
Download PDFs >
Cancer Drug Resistance
ISSN 2578-532X (Online)
[email protected]
Navigation
Contact Us
Sitemap
Follow Us
LinkedIn
Twitter
WeChat
Navigation
Contact Us
Sitemap
Committee on Publication Ethics
https://members.publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Committee on Publication Ethics
https://members.publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/